Related Experiment Video
Updated: Jun 10, 2026

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease
This consensus statement provides recommendations for managing colorectal cancer, including hepatic and pulmonary metastases, monoclonal antibodies, and chemotherapy in elderly patients. It also covers gastrointestinal neuroendocrine tumors and gastric cancer.
Area of Science:
- Oncology
- Gastroenterology
Background:
- The Eastern Canadian Colorectal Cancer Consensus Conference convenes experts to discuss and update management strategies.
- Colorectal cancer care requires addressing complex issues like metastasis and treatment in diverse patient populations.
Purpose of the Study:
- To develop evidence-based recommendations for the management of colorectal cancer.
- To address current challenges in colorectal cancer treatment, including metastatic disease and specific patient groups.
- To provide guidance on related gastrointestinal malignancies.
Main Methods:
- Expert consensus development through presentations and discussions at the annual conference.
- Review of current literature and clinical practice for colorectal cancer management.
- Focus on key areas: hepatic/pulmonary metastases, EGFR inhibitors, and elderly patient chemotherapy.
Main Results:
- Key recommendations were formulated regarding the management of colorectal cancer.
- Specific guidance was developed for treating hepatic and pulmonary metastases.
- The role of monoclonal antibodies targeting the epidermal growth factor receptor was evaluated.
- Chemotherapy benefits and safety in elderly colorectal cancer patients were assessed.
- Management strategies for gastrointestinal neuroendocrine tumors and gastric cancer were discussed.
Conclusions:
- The consensus provides updated guidelines for optimal colorectal cancer patient care.
- The recommendations aim to improve treatment outcomes for metastatic colorectal cancer.
- Consideration of novel therapies and special populations is crucial for effective management.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
06:46Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
Published on: January 9, 2026